These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10872096)

  • 1. Optimization and development of a core-in-cup tablet for modulated release of theophylline in simulated gastrointestinal fluids.
    Danckwerts MP
    Drug Dev Ind Pharm; 2000 Jul; 26(7):767-72. PubMed ID: 10872096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zero-order release of theophylline from a core-in-cup tablet in sequenced simulated gastric and intestinal fluid.
    Danckwerts MP; van der Watt JG; Moodley I
    Drug Dev Ind Pharm; 1998 Feb; 24(2):163-7. PubMed ID: 15605446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic evaluation in dogs of theophylline in a novel zero-order release core-in-cup tablet.
    Danckwerts MP; van der Watt JG; Moodley I
    Biopharm Drug Dispos; 1998 Nov; 19(8):517-22. PubMed ID: 9840213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and optimization of colon-targeted system of theophylline for chronotherapy of nocturnal asthma.
    Patel MM; Amin AF
    J Pharm Sci; 2011 May; 100(5):1760-72. PubMed ID: 21154966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of acryclic and metacrylic acid derivatives as sustained release matrices for theophylline hydrate tablets.
    Ofoefule SI; Chukwu A
    Boll Chim Farm; 1999 Nov; 138(10):526-30. PubMed ID: 10765469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new drug delivery system using plasma-irradiated pharmaceutical aids. V. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of a wall material containing polybenzylmethacrylate.
    Ishikawa M; Noguchi T; Niwa J; Kuzuya M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2215-20. PubMed ID: 8582024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled porosity osmotic pump system with biphasic release of theophylline: influence of weight gain on its in vivo pharmacokinetics.
    Bi Y; Zhang Y; Zhao J; Mao S; Hou S
    Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):792-5. PubMed ID: 18520082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Slow-release theophylline for the treatment of asthmatic children].
    Iwasaki E; Baba M
    Nihon Rinsho; 1996 Nov; 54(11):3102-7. PubMed ID: 8950962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
    Kadam VD; Gattani SG
    Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new sustained-release theophylline tablet for children.
    Selvig K; Alme A; Rugstad HE; Aas K; Bjerve KS
    Acta Paediatr Scand; 1981 Nov; 70(6):929-33. PubMed ID: 7324949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new drug delivery system using plasma-irradiated pharmaceutical aids. VI. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of water-soluble polymers as a wall material.
    Kuzuya M; Ishikawa M; Noguchi T; Niwa J; Kondo S
    Chem Pharm Bull (Tokyo); 1996 Jan; 44(1):192-5. PubMed ID: 8582038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of chitosan/Kollicoat SR 30D film-coated tablets for colonic drug delivery.
    Fan LF; He W; Chang YZ; Xiang B; Du Q; Wang F; Qin M; Cao DY
    Int J Pharm; 2009 Jun; 375(1-2):8-15. PubMed ID: 19457627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.